Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

Source:http://linkedlifedata.com/resource/pubmed/id/20406831

Clin. Cancer Res. 2010 May 1 16 9 2634-45

Download in:

View as

General Info

PMID
20406831